Poorly differentiated thyroid carcinoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Akslen LA, Livolsi VA (2000) Poorly differentiated thyroid carcinoma—It is important. Am J Surg Pathol 24:310–313
Asioli S, Erickson LA, Righi A et al (2010) Poorly differentiated carcinoma of the thyroid: Validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol 23:1269–1278
Barwad A, Dey P, Nahar Saikia U et al (2012) Fine needle aspiration cytology of insular carcinoma of thyroid. Diagn Cytopathol 40(S1):E43–E47
Bichoo RA, Mishra A, Kumari N et al (2019) Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: Is there any difference? Langenbecks Arch Surg 404(1):45–53
Bongiovanni M, Bloom L, Krane JF et al (2009) Cytomorphologic features of poorly differentiated thyroid carcinoma: A multi-institutional analysis of 40 cases. Cancer Cytopathol 117:185–194
Bongiovanni M, Faquin WC (2010) Poorly differentiated thyroid carcinoma. In: Ali SZ, Cibas E (eds) The Bethesda system for reporting thyroid cytopathology. Springer, New York, pp 129–138
Boos LA, Dettmer M, Schmitt A et al (2013) Diagnostic and prognostic implications of the PAX8-PPARgamma translocation in thyroid carcinomas—A TMA-based study of 226 cases. Histopathology 63:234–241
Brierley J, Tsang R, Panzarella T et al (2005) Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf) 63:418–427
Brierley JD, Gospodarowicz MK, Wittekind C (eds) (2017) TNM classification of malignant tumours, 8 edn. Wiley-Blackwell, Hoboken
Brose MS, Nutting CM, Jarzab B et al (2014) Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: A randomised, double-blind, phase 3 trial. Lancet 384(9940):319–328
Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159(3):676–690
Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ „wuchernde Struma“. Am J Surg Pathol 8:655–668
Delellis R, Lloyd R, Heitz P, Eng C (eds) (2004) Pathology and genetics of tumours of endocrine organs, 3 edn. World Health Organization classification of tumours, vol 8. IARC, Lyon
Dettmer M, Schmitt A, Steinert H et al (2011) Poorly differentiated thyroid carcinomas: How much poorly differentiated is needed? Am J Surg Pathol 35:1866–1872
Dettmer M, Schmitt A, Steinert H et al (2012) Poorly differentiated oncocytic thyroid carcinoma—Diagnostic implications and outcome. Histopathology 60:1045–1051
Dettmer M, Perren A, Moch H et al (2013) Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma. Thyroid 23:1383–1389
Dettmer M, Vogetseder A, Durso MB et al (2013) MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas. J Clin Endocrinol Metab 98:E1–7
Dettmer MS, Perren A, Moch H et al (2014) MicroRNA profile of poorly differentiated thyroid carcinomas: New diagnostic and prognostic insights. J Mol Endocrinol 52:181–189
Dettmer MS, Schmitt A, Steinert H et al (2015) Tall cell papillary thyroid carcinoma: New diagnostic criteria and mutations in BRAF and TERT. Endocr Relat Cancer 22:419–429
Erickson LA, Lloyd RV (2004) Practical markers used in the diagnosis of endocrine tumors. Adv Anat Pathol 11:175–189
Granner DK, Buckwalter JA (1963) Poorly differentiated carcinoma of the thyroid gland. Surg Gynecol Obstet 116:650–656
Ibrahimpasic T, Ghossein R, Carlson DL et al (2014) Outcomes in patients with poorly differentiated thyroid carcinoma. J Clin Endocrinol Metab 99:1245–1252
Ibrahimpasic T, Xu B, Landa I et al (2017) Genomic alterations in fatal forms of non-anaplastic thyroid cancer: Identification of MED12 and RBM10 as novel thyroid cancer genes associated with tumor virulence. Clin Cancer Res 23:5970–5980
Ibrahimpasic T, Ghossein RM, Shah JP et al (2019) Poorly differentiated carcinoma of the thyroid gland: Current status and future prospects. Thyroid 29(3):311–321
National Cancer Institute https://www.cancer.gov/about-cancer/treatment/drugs/thyroid . Accessed 14 Febr 2019
Ito Y, Miyauchi A, Hirokawa M et al (2018) Prognostic value of the 8(th) tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan. Endocr J 65:621–627
Jung TS, Kim TY, Kim KW et al (2007) Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. Endocr J 54:265–274
Kane SV, Sharma TP (2015) Cytologic diagnostic approach to poorly differentiated thyroid carcinoma: A single-institution study. Cancer Cytopathol 123:82–91
Landa I, Ibrahimpasic T, Boucai L et al (2016) Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest 126:1052–1066
Langhans T (1907) Über die epithelialen Formen der malignen Struma. Virchows Arch Pathol Anat Physiol Klin Med 189:69–152
Lin F, Prichard J (eds) (2015) Handbook of practical immunohistochemistry—Frequently asked questions. Springer, New York, Heidelberg, Dordrecht, London
Lloyd RV, Osamura RY, Klöppel G, Rosai J (eds) (2017) WHO classification of tumours of endocrine organs, 4 edn. WHO classification of tumours, vol 10. IARC, Lyon
National Cancer Institute (2019) SEER cancer statistics review, 1975–2015. Seer cancer stat facts: Thyroid cancer
Nikiforov YE, Nikiforova MN (2011) Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 7:569–580
Nikiforov YE, Biddinger PW, Thompson LD (eds) (2012) Diagnostic pathology and molecular genetics of the thyroid. Lippincott Williams & Wilkins, Philadelphia
Papotti M, Botto Micca F, Favero A et al (1993) Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol 17:291–301
Pilotti S, Collini P, Manzari A et al (1995) Poorly differentiated forms of papillary thyroid carcinoma: Distinctive entities or morphological patterns? Semin Diagn Pathol 12:249–255
Pulcrano M, Boukheris H, Talbot M et al (2007) Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid 17:639–646
Purkait S, Agarwal S, Mathur SR et al (2016) Fine needle aspiration cytology features of poorly differentiated thyroid carcinoma. Cytopathology 27:176–184
Rodrigues RF, Roque L, Rosa-Santos J et al (2004) Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas. Br J Cancer 90:492–496
Saglietti C, Onenerk AM, Faquin WC et al (2017) FNA diagnosis of poorly differentiated thyroid carcinoma. A review of the recent literature. Cytopathology 28:467–474
Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849–1855
Sanders EM Jr., Livolsi VA, Brierley J et al (2007) An evidence-based review of poorly differentiated thyroid cancer. World J Surg 31:934–945
Sasanakietkul T, Murtha TD, Javid M et al (2018) Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer. Mol Cell Endocrinol 469:23–37
Schlumberger M, Tahara M, Wirth LJ et al (2015) Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med 372:621–630
Soares P, Lima J, Preto A et al (2011) Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Curr Genomics 12:609–617
Sugitani I, Kasai N, Fujimoto Y et al (2001) Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 25:617–622
Van Den Brekel MW, Hekkenberg RJ, Asa SL et al (1997) Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngoscope 107:254–259
Viola D, Valerio L, Molinaro E et al (2016) Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience. Endocr Relat Cancer 23:R185–205
Volante M, Collini P, Nikiforov YE et al (2007) Poorly differentiated thyroid carcinoma: The Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–1264
Volante M, Rapa I, Papotti M (2008) Poorly differentiated thyroid carcinoma: Diagnostic features and controversial issues. Endocr Pathol 19:150–155
Volante M, Rapa I, Gandhi M et al (2009) RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab 94:4735–4741
Wreesmann VB, Ghossein RA, Patel SG et al (2002) Genome-wide appraisal of thyroid cancer progression. Am J Pathol 161:1549–1556
Yang H, Chen Z, Wu M et al (2016) Remarkable response in 2 cases of advanced poorly differentiated thyroid carcinoma with liposomal doxorubicin plus cisplatin. Cancer Biol Ther 17:693–697
Zulewski H, Giovanella L, Bilz S et al (2019) Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland. Swiss Med Wkly 149:w14700